Apr 13, 2017 12:10 pm UTC| Business
-- Late-breaking oral presentations to highlight data from plazomicin Phase 3 EPIC and CARE clinical trials -- -- Newly-released in vitro data demonstrates activity of plazomicin against a large collection of...
Apr 13, 2017 12:10 pm UTC| Business
-- Late-breaking oral presentations to highlight data from plazomicin Phase 3 EPIC and CARE clinical trials -- -- Newly-released in vitro data demonstrates activity of plazomicin against a large collection of...
CoreCivic Announces Contract Extension at the Houston Processing Center
Apr 13, 2017 12:10 pm UTC| Business
NASHVILLE, Tenn., April 13, 2017 -- CoreCivic, Inc. (NYSE:CXW) (the “Company") announced today that it received a contract extension from Immigration and Customs Enforcement ("ICE") at CoreCivic's 1,000-bed Houston...
CoreCivic Announces Contract Extension at the Houston Processing Center
Apr 13, 2017 12:10 pm UTC| Business
NASHVILLE, Tenn., April 13, 2017 -- CoreCivic, Inc. (NYSE:CXW) (the “Company") announced today that it received a contract extension from Immigration and Customs Enforcement ("ICE") at CoreCivic's 1,000-bed Houston...
Apr 13, 2017 12:10 pm UTC| Business
-- Late-breaking oral presentations to highlight data from plazomicin Phase 3 EPIC and CARE clinical trials -- -- Newly-released in vitro data demonstrates activity of plazomicin against a large collection of...
Apr 13, 2017 12:10 pm UTC| Business
-- Late-breaking oral presentations to highlight data from plazomicin Phase 3 EPIC and CARE clinical trials -- -- Newly-released in vitro data demonstrates activity of plazomicin against a large collection of...
Apr 13, 2017 12:10 pm UTC| Business
-- Late-breaking oral presentations to highlight data from plazomicin Phase 3 EPIC and CARE clinical trials -- -- Newly-released in vitro data demonstrates activity of plazomicin against a large collection of...